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Summary
We have examined at the molecular level the CDR3 and adjacent regions in peripheral blood
B lymphocytes ofnormal individuals. A total of 111 sequences (12-28 sequences from six individuals)
were obtained after cloning of the polymerase chain reaction-amplified segments into plasmids
or phage . The average length of the VDJ joining was 109 nucleotides, with a range from 79
to 151 . Approximately 75% of the sequences were in frame when translated into amino acids .
Among the JH segments, JH4 was found most frequently (in 52.5% of the sequences), and JH1
and JH2 segments the least frequently (-I% of the clones) . A polymorphic JH6 gene with a
one-codnn deletion accompanied by a base change was present in two ofsix patients. Preferential
breakpoints were found for JH2, J.3, J4, and Jx5, although the breakpoints of JH6 were
distributed more heterogenously.
In -90% of the cases, significant homology of the D regions with published D sequences
was found . Preferential usage of a particular coding frame was observed in in-frame sequences
utilizing DA, D21/9, and DMl segments. However, in general, all coding frames of germline
D genes were used to generate CDR3s . Eight sequences that have a DN1-like D sequence with
two base changes at the same positions were identified, suggesting the likely existence of anew
germ lineD gene belonging to theDN families . Using probes specific for a particular CDR3,
the frequency of a specific B cell clone in the peripheral blood of normal individuals was estimated
to be at most as high as 1/20,000 .
T
he most variable region of the immunoglobulin heavy
chain is the third complementarity determining region
(CDR3) (1, 2) . This region spans the junction between the
variable (V ) diversity (D), and junctional 0,,) segments in
the rearranged IgH genes (1, 2) . The hypervariability of this
region is due to the combinatorial assortment of the many
V , D, and JH segments that are utilized to generate a par-
ticular CDR3, to the imprecise joining mechanisms that in-
clude deletion ofbases from the potential coding regions of
each segment to bejoined (3), and the addition ofnew bases
that can be enzymatically added at the point ofjoining (N
regions) (4) . Finally, somatic mutations of the rearranged re-
gion can contribute to the production ofhigher affinity anti-
bodies (5) .
The nucleotide sequences of all the humanD genes, esti-
mated to be -30 in number (6), have not been fully defined,
and questions remain about the relative usage of different D
genes used in VDJjoinings during development and in adult
individuals . Furthermore, the characteristics of the extent of
base excision and addition, including the identification of
preferred sequence boundaries for the V., D, and J regions,
have not been well delineated. The relative frequency of in-
frame translation products reflecting productive rearrange-
ments, and the possibility of specific translation frames being
preferred for particular D gene families have not been deter-
mined on a large sample size.
To address these questions, we have used the method of
thePCR (7, 8) using primers for framework region (3) (FR3)
of the V segments and for the Jx genes to amplify the
CDR3s and adjacent regions (9) from a polyclonal popula-
tion of peripheral blood B lymphocytes. The amplifiedCDR3s
have been sequenced from plasmids or phage libraries .
The resulting analysis of 111 CDR3 sequences from six
adult volunteers gives a picture not only of the usage of var-
ious D family and JH gene segments and of the translational
frame used in individual D family genes, but also extends
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aries, the frequency of in-frame products in circulatingB cells
of normal individuals, andthetype ofpolymorphisms present
in the human JN gene locus . Also, we provide further evi-
dence that novel rearrangements (V.-J,,, V,;inverted D-J.,
V.-DIRJ, V-D-DJH, V.D-invertedD-J., V,rDIRDJH,
V-inverted DIR-DJH , and VHD-DIRJ) are commonly
present in the circulating B cell population supporting the
original hypothesis of Kurosawa and Tonegawa (3), that al-
ternative signal sequences present in certainD segments may
be responsible for this breakin the 12/23-bp spacer recombi-
nation rule (10) .
Materials and Methods
Clinical SamplesandDNA Preparation .
￿
Peripheral blood (10 ml)
was obtained by venipuncture from six healthy adult volunteers.
Low-density mononuclear cells were obtained by fractionation on
aFicoll/Hypaque gradient (d=1.078) (11) . High molecular weight
genomicDNA was isolated from mononuclear cells using estab-
lished methods (12).
Oligonucleotide Primers and Probes.
￿
Oligonucleotides were syn-
thesized by the solid phase triester methodology on aDNA syn-
thesizer (380A; Applied Biosystems, Inc., Foster City, CA) (13).
The senseand antisense primers containing the SalI and PstI cloning
sites, homologous to theV FR3 and the Jx genes, used for am-
plification of the VDJjoining region of the IgH, were 5' CTG-
TCGACACGGCCGTGTATTACTG-3' and 5' AACTGCAGAG-
GAGACGGTGACC-3', respectively. In some experiments, to
exclude a possible bias in amplification of the JH segments, primers
specific for Jx2 and Jx3 were used . These J2 and JN3 primers
differed from the antisense universal Ja primer by a G to A base
substitution at positions 16 and 9 of the universal Jx primer,
respectively. The JH consensus (JC) probes, which were used to
detect allVDJrearrangements, were a mixture of four oligonucle-
otides derived from the sequences of J2, Jx3, J4, andJ6 genes
just 5' to the Jx antisense primer used for PCR amplification.
These oligonucleotides had the following sequences ; JH2: 5'-CTG-
GGGCCGTGGCACCCTGG-3' ; Jx3 : 5'-CT000GCCAAGGGA-
CAATGG-3; J4 : 5'-CTGGGGCCAGGGAACCCTGG-3; J6 :
5'-TCTGGGGCAAAGGGACCACG-3
TheJ4 probe also hybridized to J1 andJH5 sequences when
42°C and 45°C were used as the hybridization and washing tem-
peratures, respectively.
PCR, Cloning, and Sequencing ofVDJJoining.
￿
PCR was car-
ried out as described by Saiki et al . (7) and Mullis and Faloona
(8) . The initial denaturation step was at 95°C for 5min, followed
by 30 cycles with a 1-min annealing step at 55°C, a 2-min elonga-
tion step at 70°C, and a 2-min denaturation step at 95°C . The
final cycle was completed with a 7-min elongation step. Samples
were extracted with phenol/chloroform, precipitated with ethanol,
and resuspended in Tris-EDTA buffer. Precautions against cross-
contamination of amplified material were taken according to the
recommendations of Kwok et al . (14) .
After phenol/chloroform extraction andethanol precipitation,
an aliquot of thePCR-amplified material was digested with both
Sall and PstI restriction endonucleases (BoehringerMannheim Bio-
chemicals, Indianapolis, IN) . After electrophoresis in a4% Nusieve
agarose gel (FMC, Rockland, ME), slices spanning the 72-191-bp
region, which contain the amplified CDR3 DNA, were treated
with agarose (15) (Calbiochem-Behring Corp., San Diego, CA).
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RecoveredDNA was ligated into Bluescript phagemid (Stratagene,
La Jolla, CA) and transfected into Escherichia coli strainJM 109 (16) .
Transformants were lifted onto nitrocellulose filters (BA 85 ;
Schleicher & Schuell, Inc., Keene, NH). The filters were hybrid-
ized at 42°C with "P-labeled J.C probes andwere washed in 6x
SSC and 0.1% SDS at 45°C. Lower stringency of washing was
used in order not to miss any VDJ clones with polymorphisms
in the areas homologous to theJHC probes used.
Positive clones were picked up randomly, and double-stranded
DNA template was prepared andsequenced by themethod ofSanger
et al . (17) using the Sequenase kit (United States Biochemical Corp.,
Cleveland, OH) .
Computer Analysis ofDNA Sequences.
￿
Computer analysis of
DNA sequencing data wasperformedusing the sequence analysis
software package of the Genetic Computer Corp., Release 5, of
the University ofWisconsin andaMicroVax II computer (Digital
Equipment Corp., Marlboro, MA).
All VDJjoining sequences were entered using the "seqed" pro-
gram . Each sequence was checked for the presence, in the correct
orientation, of the JN andV primers. Each VDJjoining sequence
was translated into the predicted amino acids, using the following
criteria to identify in-frame sequences . (a)Theamino acid sequence
of the V primer in FR3 starts with VDTAVYY (C) . (b) The
amino acid sequence of the JH primer ends up with VTVSS (A) .
(c) No stop codons should be present in between the two primer
coded sequences. Each sequence was searched for homology with
the six human JH sequences (18) available in a subdirectory using
the "word search" program .
Each sequence was searched forhomology against all published
D genes (6, 19, 20) available in a second subdirectory. The best-fit
D genes were chosen according to the following criteria; (for Fig.
7, we dropped criteria a and e) . (a) We did not accept reverse ho-
mology. (b) We gave priority to the homology with aJ segment,
when bothD and JH homologous regions overlapped . (c) When
we hadmore than one candidate, we took the longest stretch with
the highesthomology. (d) We tried to avoid introducing gaps and
base additions to the alignment . However, if there were no other
candidates andthe stretch of homology was long enough,we took
the sequence with the gap or base additions . (e) We did not use
homology toDIR sequences . According to this computer analysis,
sequences of the VDJjoinings examined were subdivided into V,
D, and J,, segments .
Generation and Screening ofM13 Libraries of VDJJoining Clones.
PCR-amplified materials from donors 2, 3, and 4were ligated into
M13 mp19 (Bethesda Research Laboratories, Gaithersburg, MD)
phage vector using the same protocol used for Bluescript transfor-
mation . Ligated materials were then used to transform DH5ciF'
E. coli, and N5-10 x 101 plaques per 15-cm plates were transferred
to nitrocellulose filters to generate replica filters. Duplicate filters
were screened separately with the JHC probes to establish the
number ofVDJ joinings present in the libraries and with diag-
nostic oligonucleotide probes homologous to theNregions ofran-
domly picked VDJjoinings to establish the frequency of a specific
CDR3 sequence in the overall population .
The frequency ofJx2 segment usage in the population was de-
termined by screening separately a largenumber of M13 clones con-
taining VDJjoinings on duplicate filters with theJNCprobes that
hybridize to all six JH genes and with theJ.2-specific probe . Strin-
gent hybridization conditions (washing the filters at 1°C below
the melting temperature of the probe) were used with the JN2
probe in order to avoid crosshybridization with other Jx segments .
12 of the plaques that hybridized to the J2 probe were isolated
and sequenced .Results
Characteristics ofthe CDR3 in NormalBLymphocytes.
￿
DNA
sequences that contain theCDR3 and adjacent regions span-
ning from the FR3 of V to the 3' end ofJH were obtained
from PBL of six healthy adult volunteers .
Fig. 1 contains the sequences of 99 randomly picked VDJ
joinings as well as 12 VDJ joinings containing JH2 segments
that have been isolated using a J.2-specific diagnostic probe.
Palindromic nucleotides generated during the joining pro-
cess, as described by Lafaille et al . (21), are shown when present
as full tetrameric palindromes . In the 111 total CDR3 se-
quences, nine were found at the 3' V border, five at the 5'
D border, one at the 3' D border, and one at the 5' V
border.
Fig. 2 shows the predicted amino acid sequences of the
CDR3 and adjacent regions . 75% (75/99) of the randomly
picked sequences were in-frame when translated into amino
acids. 7 of 12 VDJ joinings with J,,2 segments (58%) were
in-frame. The in-frame sequences from Fig. 1 are grouped
according to the JN utilized and are listed in an increasing
order of length . The reading frame for eachD segment is
also indicated .
Fig. 3 shows the length distribution of the 99 randomly
picked VDJ joinings shown in Fig. 1. Clone 3-79 (Fig. 1)
is the shortestCDR3 identified, and it is an in-frame sequence
that codes for only a four-amino acid-long CDR3 (Fig . 2) .
Clone 1-139 (Fig . 1) is the longest in-frame sequence that
codes for a 24-amino acid-long CDR3 (Fig. 2) . Clone 1-151
(Fig . 1) is the longest out-of-frame sequence. Although the
length of the CDR3s are very heterogenous, ranging from
4 to 24 amino acids, the majority of clones range from 8
to 18 amino acids . Only one of four clones that were longer
then 136 by are in-frame, in contrast to the smaller sequences
in which the majority are in-frame.
Characteristics oftheJH Regions Utilized in AdultB Lympho-
cytes. Table 1 shows the frequency ofJH gene usage in adult
peripheral lymphocytes calculated from the 99 VDJ sequences
shown in Fig . 1, which were amplified with the J universal
primer. The most frequently found JH segments are J.4
(52.5%), Jx6 (22.2%), and JN5 (15.2%) . Only one VDJ
clone carrying a J1 segment and no clones containing a JH2
segment were identifiedamong the 99 clones randomly picked.
Experiments were done to rule out the possibility that the
J universal primer was biased in its amplification ofJ.2 and
JH3 segments due to one-base mismatch with these se-
quences . Three J primers 100% homologous to J2, J3, and
Ja were synthesized and used individually to amplify the
CDR3 of the PBL of donor 3 . The amplified products
resulting from each J primer were cloned in Bluescripts and
screened with probes specific for J2 , J3 , and Ja . The data (not
shown) indicate that no differences in the frequency of JH2,
JH3, and JH4 containing recombinant clones were observed
when either the J. universal or JH3 or JH2 primers were used
in the PCR .
Table 2 shows the frequency of JH2 gene usage as deter-
mined by screening an M13 library containing CDR3-
amplified sequences with a J.2-specific oligonucleotide probe
(see Materials and Methods section) . The calculated frequency
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of JH2 gene usage ranged from 0.98 to 1.77% in the three
donors studied .
Fig . 4 shows the sequences present in the six donors in
JH3, JH4, JH5, and JH6 gene segments as compared with the
sequences originally published by Ravetch et al . (18) . These
variant sequences have all been published previously (18, 22,
23) . JH3b differs from J3a by one base (G to A), which
results in an amino acid change from V to I. JH5b differs
from JH5a by three bases (C to A, A to G, T to C), of which
the latter base change results in an amino acid change from
S to P. J6c has three consecutive base deletions (GGT),
which eliminates an amino acid, and one base change (C to
A), which results in an amino acid change fromQ to Kwhen
compared with JH6b . JH4b and JH6b differ from J4a and J6a
by one base change, respectively, which does not result in
an amino acid change .
Jx3b, JH4b, and JH5b segments were exclusively used by all
six donors . For JH3 and J.5, there were one and three se-
quences, respectively, which could not be assigned to an a
or b sequence because the break point was downstream from
where they differed . These findings and other findings in the
literature (23) indicate that JH3b, JH4b, and J5b sequences
should be considered as prototype sequences instead ofJ3a,
J4a, and J5a sequences, which were originally reported as
germline JH sequences in a single individual (18) . All the JH6
sequences obtained from donor 6 used the J6c sequence.
This variant sequence was also observed in two of three JH6
sequences from donor 5, while JH6b sequences were found
exclusively in donors 1, 2, 3, and 4 . Therefore, JH6b and J6c
truly represent two different polymorphic loci .
Analysis ofRearrangement Sites at theDjJunction .
￿
Fig.
5 highlights the 5' rearrangement sites of JH segments in
VDJ joining clones . Rearrangement of the JH3 segment is
most frequently observed at the 5' end (base 1 in the Fig.
5) of the J coding sequence . Rearrangements of the J.2 and
JH5 segments are most frequently observed 2-5 by down-
stream from the 5' end of the coding sequence, whereas the
JA segments most frequently rearrange 4-9 by downstream .
Rearrangements of the JH6 segments are widely distributed
3-21 by downstream .
Characteristics ofDGene Family Usage
￿
Approximately 91%
(100/111) of the sequences from Fig . 1 had significant ho-
mology to one of the presently known germline D genes
(6, 19, 20) . Fig. 6 aligns theD regions of the sequences in
Fig. 1 to known germline D1 segments with the most ho-
mology. As seen, there is often extensive trimming of nucleo-
tides at both the 5' and 3' ends of the D segment, which
may make some of the homology assignment inaccurate. In
many cases, the homology to a given familymember is<90%,
suggesting that these sequences are probably derived from
other unknown members of the same family. Specifically for
the DN1 segments, ,8 of 19 sequences have two base pair
changes at the same .position ; i .e ., C - T at position No .
12, and A - G at position No . 13 . This variant form of
the known germline sequence is observed in all six donors .
The germlineDN4 segment, which is the only otherknown
member ofDN family, does not match the variant at posi-
tions no. 12 and no. 13 . These findings suggest the presence~ 23 ÓN2M 1 . , 91óóóóó óóóó~ .~ 5{~ @ 21 ~~~
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Figure 2 .
￿
Translated amino acid sequences of the CDR3 and adjacent
regions . 75 in-frame sequences from the 99 randomly picked VDJ clones
and seven in-frame JN2 sequences shown in Fig. 1 are included. The amino
acid sequences are grouped according to the JN segment used and lined
up in increasing order of length . Amino acids derived from the VN and
JN primer sequences may not entirely represent the original amino acids .
The first 10 amino acids are lined up as the framework region 3 (FR3),
amino acids identical to consensus sequences are shown by a bar, while
amino acids that are not identical are indicated . The second block is
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Figure 3 .
￿
Length of the CDR3 sequences deduced from the 99 VDJ
sequences from Fig. 1 . Shaded bars represent in-frame sequences, while
open bars represent out-of-frame sequences . On the x-axis, the first line
shows the length ofthe VDJjoinings sequences in basepairs . Theseclones
cover the 3' end of the FR3, the CDR3, and the FR4 . The second line
shows the length of theCDR3 in basepairs. The third line shows the length
of the CDR3 peptides (for in-frame sequences) in amino acids (aa) . The
y-axis shows the number of clones examined .
of a new D segment that belongs to the DN family. We can
not rule out the possibility that some of the other aligned
sequences are derived from related but not yet identified
members of the same family. Table 3 shows the coding frame
of the D segments used in those sequences that were found
in frame. All three coding frames were used with some
preferential use of specific coding frames in certain D genes.
5 of the six in-frame sequences carrying a DA segment used
the second coding frame . All five in-frame sequences using
aDM1 gene used the third coding frame. All four sequences
using aD21/9 gene used the second reading frame. Sequences
using theDK segments (DK1 and DK4) preferentially used
the first and third coding frames .
Possibility of Unusual VDJJoining .
￿
In 11 of 111 total se-
quences analyzed (10%), we could not find significant ho-
mology with a known D segment . In addition, several se-
quences have extraordinarily long N regions (>15 bp),
including some with homology to a known D segment . We
reexamined these sequences using less stringent criteria by
allowing for homology against both DIR and D gene seg-
ments regardless of orientation . The following are possible
unusual VDJ joinings . Fig. 7 shows examples for each of the
following categories : (a) V.-J. joining without D. (b) In-
verted D joining (V. <- D-J. joining) . (c and d) Double D
joining (V,;D-D831) and (V.--D E- D-J.) . (e andf) V,;DIR
the amino acid sequence derived from N-D-N region . Sequences homolo-
gous to germlineD genes at the nucleotide level are underlined . Amino
acids identical to those coded for by germlineD genes are shown in small
letters. The third block is the amino acid sequence derived from the germ-
line JN gene. Amino acids identical to consensus sequence are shown by
bars, while amino acids that are not identical are indicated . The first column
(*) after the sequences shows the length ofCDR3 peptide. The second
column shows theD geneused and the third column indicates the coding
frame of theD gene used . (ns) The reading frame for a particular D gene
cannot be identified due to either extensive deletion or mutation .
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.1Table 1 . JH Gene Usage in 99 Randomly Examined
D-J. joining, V,;D-DIRJ joining. (g) VHDIRJ. joining,
V.-inverted DIRJ joining.
Frequency ofSpecific CDR3 Sequences in the B Cell Popula-
tion as an Indication of Clonal Heterogeneity . To determine
whether the primers used in thePCR amplified a large number
or a relatively discrete number ofCDR3 regions, we tried
to estimate the frequency of two specific CDR3 sequences
in the PCR products amplified from the lymphocyte popu-
lation of three donors . Two oligonucleotide probes (2-106A-
DP and 2-118B-DP) were synthesized that were specific for
the CDR3 of the randomly picked VDJ clones 2-106A and
2-118B from donor 2 (underlined in Fig . 1) . Triplicate filters
of M13 libraries containing amplified CDR3s from three
normal lymphocyte samples (donor nos . 2, 3, and 4) were
J4a
Job
J6a
J6b
J6b
ATGCTrrIGATG'
-_________
J3a
￿
A F D V W G Q G T M
J4a
￿
Y F D Y W G Q G T L
N W F D S W G Q G T L
p _ _ _ _ _ _
ATTACTACTACTACTACGGTA
-_________
J6a/b
￿
Y Y Y Y Y G M D V W G Q G T T
J6c
￿
_ _ _ _ _ o _ _ _ _ _ K _ _ _
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Table 2 .
￿
Frequency of VDJJoinings Containing the JN2
Segment in Peripheral Blood B Cells
Number of recombinant clones containing CDR3 amplified sequences
present in M13 phage libraries that hybridize to aJ.2-specific probe .
t Number of clones positive for a mixture ofJx consensus probes (JNC
probes) derived from JH segment sequences 5' to the Jx primer used in
the PCR amplification.
then screened with these probes . One set of filters was hy-
bridized with the JHC probes to establish the number of the
VDJ clones present in the M13 libraries. The second and third
sets offilters were hybridized with the 2-106A-DP probe and
2-118B-DP probe, respectively, to establish the frequency of
these two specific clones in the population . As shown in Table
4, we found one positive plaque for the 2-106A-DP probe
in M13 libraries from donor no. 2 only, and not from the
other two donors (nos. 3 and 4) . No positive clones for the
2-118B-DP probe were found after screening 18,000-20,000
plaques in each donor's library. From these data, we estimate
that in the peripheral blood of donor 2, the two CDR3 se-
quences from which the probes were derived are present at
a frequency of no more than one in 20,000 different CDR3s
NO . OF CDR3
CTS
Figure 4.
￿
Sequences of JH genes . J3a, J4a, J5a,
and J6a were original sequences published by
Ravetch et al . (18) . Jx4b andJx5b were described as
polymorphisms inJ4 and JH5 genes by Schroeder et
al . (23) . J6c was first described by Ravetch as a
variant from J6 found in oneofthe two recombined
0
￿
genes from IgM-expressing chronic lymphocytic
4
￿
leukemia cells (18) .J3b also appeared in the paper by
Schroeder et al . (23), although they did notmention
it as a polymorphism . The JH6b was noted in the
work by Bird et al . (22) from rearranged IgH in leu-
kemic lymphoblasts. The first group for each J gene
0
￿
is the comparison at the nucleotide level and the second
12
￿
group is thecomparison at the peptide level . In this
0
8
0
15
7
study,J .36,Jx4b, and J5b genes were used exclusively
by all six donors while bothJ6b andJ6c genes were
used in the population . Consensus sequencesbetween
each version are shown as bar, while sequences that
are not identical are indicated . Deletions are shown
as circles. For each JN segment, the 5' coding region
begins at the first nucleotide shown . The 3' ends of
the JH segments are not shown. The number of
CDR3 clones using a specific Jx is shown in the right
column .
VDJJoinings
Donors
JH segment 1 2 3 4 5 6 Total Percent
J1 0 1 0 0 0 0 1 1.0
J2 0 0 0 0 0 0 0 0.0
J3 0 3 3 2 1 0 9 9.1
J4 8 14 4 11 7 8 52 52.5
J5 2 5 4 2 1 1 15 15.2
J6 5 5 2 2 3 5 22 22.2
Total 15 28 13 17 12 14 99 100.0
Donor
JH2
clones"
Total VDJ
joiningst
Frequency of
J,,2 clones
2 80 6,320 1 .27
3 59 6,041 0.98
4 184 10,384 1.77Discussion
Figure 5 .
￿
Analysis of the 5' junction of the JH genes in VDJ rearrange-
ments . Six germlineJx sequences are lined up from the beginningof the
heptamer signal (underlined) . Numbering starts at the fast nucleotide of
the coding sequence. The position of the 5' junction of the JN genes ob-
served in eachVDJ sequence are plotted above the nucleotide as anasterisk .
The first TG in each J gene is underlined . The 3' ends of theJx segments
are not shown .
(representing 10,000-20,000 B lymphocytes, depending on
the number of rearranged IgH alleles) . These data also indi-
cate that a single set of primers used for PCR amplification
of VDJ joinings is able to amplify a very large proportion,
if not the total representative population of the CDR3 re-
gion present in normal lymphocytes .
We report a detailed analysis of thehumanH chain CDR3
present in the peripheral blood B lymphocytes of six healthy
adults . To do so, we have amplified the CDR3 present in
the cell population using thePCR with primers that are ho-
mologous to the 3' end of the JH segment (antisense primer)
and to the FR3 of the V segments (sense primer) (9) .
The data obtained indicate that JH4 and JH6 segments are
the most commonly found JH segments in adult peripheral
lymphocytes ofCDR3, and that JH1 and J2 are the least fre-
quently found . Schroeder et al . analyzed 15 IgH sequences
in human fetal liver and reported a predominance of tran-
scripts of JH3 (seven clones), J4 (six clones), and JH5 (two
clones) (23) . It is not clear at the present time if the differ-
ences between Schroeder's findings and ours are due to the
small sampling in their study or different utilization or selec-
tion of JH segments in a fetal vs. an adult B cell population .
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* Frame is not known because of extensive mutations, or base deletions,
however, enough homology is present to assign the sequence to aknown
D gene .
t TheD gene cannot be identified .
4 75 in-frame sequences four 99 randomly picked clones and seven in-
frame sequences obtained by screening with the JH2 probe are included .
The sites ofJH gene rearrangement have been proposed to
occur primarily at TG nucleotide sequences within the Jx
gene segments (23) . This observation appears to be applicable
to our results. In the JH3 sequence, TG first appears at posi-
tion no. 2 . In JH2, JH5, and JH4, TG first appears at nucleo-
tide position nos . 5, 6, and 8, respectively . After rearrange-
ments, most of the 5' borders of these J segments seem to
be clustered upstream of or around the firstTG . On the other
hand, TG first appears at position 22 in the JH6 sequence,
Table 4.
￿
Frequency of a Specific CDR3 Sequence among a
Polyclonal Population of Peripheral Blood B Cells
* Number of clones in M13 libraries that were positive for a mixture
of JH consensus probes (JC probes) .
1 10 20 30 Table 3. Usage ofD Coding Frame in CDR3 Peptides
JHl
*
D genes 1st 2nd 3rd Unknown* Total
x *
x**
xxx*x * XP4 1 2 4 0 7
XP1 1 2 0 0 3
x XP'l 5 4 1 0 10
* D21/9 0 4 0 0 4
JH3 ~T ATOCTrrrrAT TG . . . Al/4 1 5 0 0 6
x K4 2 0 1 1 4
*
x K1 0 1 3 2 6
*xx x N4 2 1 0 0 3
xxx *
x x*xx x N1 5 4 2 1 12
x xxxx x
* xxx**xx Ml 0 0 5 0 5
* xxxx*xx * M2 1 0 0 0 1
xxxx*xxxx *
JH4 LR5 0 0 1 1 2
** x LR4 0 2 0 1 3
xx * LR1 0 0 0 0 0
*xx x xx
LR2 0 1 0 1 2
x x LR3 0 1 1 0 2
*xxx x ** HQ52 0 1 0 0 1
xxx**x xx x**x
JH6 CBTTs"~, NSt - - - - 11
1 10 20 30 40
Totals 20 28 16 7 82
Donors
No . of clones
positive for
2-106A DP
No . of clones
positive for
2-118B-DP
Total no . of
CDR3 sequences
screened*
2 1 0 18,960
3 0 0 18,026
4 0 0 21,168A
CON3 SEQ.
1 1-91
_______C-_____C______
- G insert between bases 11 and 15
B
GERRLIRE DK1
1 10
￿
20
GTGGRTRCAGCTRTGGTTRC
2 I-127
￿
------------
3 2-916 _____C
￿
C___
1 2-1150
￿
-------------
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1 10
GOO71ITTOTROTR6TRCTHCTTTCTfl76CC
CON3 SEQ .
I 5-115R
￿
------
2 6-00
￿
-G-G---C-RG-
GERRLIRE 01 .115
CDR3 SEQ .
CON3 SEQ .
GERRLIRE JIP'I
GTRTTACTRTGGTTC66660 0 167TATTAT3 R10 1C CDRI
1U110 .
GERRLIRE OR1
I 10 20
6667ATR0006CRGCTGGTRC
_____G__
1 1-660 2 1-1100 _______TG_____
2 1-106 _____ 3 1-151 -------------------
7 2-102R _________R_R__R- 1 2-I1 DC ----------------
1 2-1090 5 2-1200 ----TG------T-
5 3-110 -----------------
6 3-9111
-------- 6 1-00 7 3-1096 __R_______________
7 1-9111 0 3-III --------------
0 1-10011 __C________
9 4-946 __R_C_____
9 1-1150 ___________R_ 10 1-97 -----------
10 6-97 _6____6_6__________ 11 4-106 ___________7G_____
11 6-110 ----- 12 5-105 ----------
12 J2-105 ------ 13 5-112 __________76______
13 J2-110 -------------------- -------------------- 11 6-127 ___________76_____
11 J2-139 ----------------------C_RG__ 15 J2-10611 ----------------
GERRLIRE XP I 16 J2-1060 --CC-RC----
I 10 20 30
17 J2-107 -G----TG-----
6TNTTRCGHTRTTTT6RCTGGT7RTTOTRRC 10 J2-109 ____TG________
CDR3 SEQ . 19 J2-12011 _C_7------TG--
I 1-170 ---------------------------
2 2-1111 ____________G____________
GERRLIRE DRI/1
3 1-115
1 10
GERRLIRE 021/9
TGRCTOCRGTRRCTRC
CDR3 SEQ .
CON3 SEQ. GTRTTRCTBT6RTRGTHGTGG7TRTTRCTRC
I 1-101
2 2-1039
------T_CG_____
-------G__G_____
I 1-121 __________________________C____ 3 2-1098 ------G-G-C--C-
2 2-10311 1 1-121 -------G___C__
3 2-1090 5 5-1030 ------------
1 2-11511 _C-----------------------C_ 6 6-05 ------
5 2-12111 __________________________G__ 7 6-91 ___6G_G______
6 6-100
9 6-103 ------G------T_
5 2-1216
6 1-120
CDR3 SEQ .
I 2-103C
_6________
G_R__R__
GERRLIRE OK1
1 10 20
GTG6RTRTNGT000TRCGRTTRC
___CG__W------R__
GERRLIRE OLR1
1 10 20 30
RGGRTRTTGTRGIRGTRCCRGCT6CTRT000
COR3 SEQ.
1 1-112
2 2-122 -------------------------
7 3-100 -------
2 2-10611 _____ __CC-___
1 5-121 ------C___G_GT__T___C_
3 2-109C _0---___ 5 5-130 -----------------------------
1 3-126 6________
GERRLIRE BLOT
5 1-133 ----------
1 10 20 JO
6 J2-106C -------G-G- RGGRTRTTGTRCTRRTGGTGTRTGCTRTRCC
7 J2-121 -------R__R_
CDR3 SEC .
GERRLIRE MIT
1 10
6GTR7RRC7GGRRCTRC
I 5-910 -O---G-CGC------
GERRLIRE OLR2
I 10 20 30
RGGRYRTT6TOGTGGTGGTRGCTGCTRCTCC
1 2-1026 CDR3 SEQ .
2 3-1036 ____________6__ 1 2-111 _G___GO----R____
3 1-91C _6______ 2 2-12011 ___GO----R-----7RT_R___
1 1-1006 ------------- 3 1-910 -----CGG-_____
5 1-109 -------TR___ 1 5-10711 _fl--------CT_G_R____
6 5-109 ------GTG---T----
CONS SEC
1 I-11011
GENUINE ONP4
I 10 20 30
GTATTACGRTTT77GGRGTGGTTRTTfl7RCC
_____________________G_________ CON3 SEQ.
GENUINE Dili
1 10
GRGTR7RGCNGCTCGTCC
2 1-139 ________________________CC_____ 1 2-9111 __________C_
3 2-1060 -------------------- 2 2-1160 ----------------
1 2-11011 3 3-97
5 3-10311 1 6-111 ___11______
6 5-1150 5 6-120
7 6-109
GERRLIRE 11112
1 10
GGTR7RR000GRRCCRC
CDR3 SEC .
CDR3 SEQ .
1 1-1151
GERRLIRE OLR3
1 10 20
RGCRTRTTGTGGTGGTORTTGCTRTTCC
-----------C_0___C----C_
1 3-910 2 6-112 ______CT_ Figure 6. Alignment of theCDR3 sequences
7 J2-110 _G_______ that havehomologyto known germlineDgenes .
In the top line of each panel, the germline D
" C insert between bases 6 and 7
GERRLIRE 11052
1 10 coding sequence is presented . Nucleotides that
e
AGO
eodon Insert between bases 10 and II
CDR3 SEQ.
CTRRCTGGGGR are different to the germlineDgenes are shown,
6 insert between bases 5 and 6 1 2-1030 while one that are identical are shown by bars.A
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￿
U-J Joining
U M
￿
J5
3-79
￿
TpCTAGA GGGGT,fl ~f'CCCTGGGGCCRGGGRRCCCT
U M
￿
,18
3-04
￿
TRCCCRCR jrS TRCGGTRTGGRCGTCTGGGGCCMGGGRCCRC
6-101
￿
TGCGRGR CGTGC "RRGCGG RCTRCTRCRRCTnCRTGGIICGTCTGGGGCGRRGGGRCCRC
0
￿
U-(Inverted)D-J Joining
30
￿
OMP4 (Inverted)
￿
1
GGTRTRRTRRCCRCTCCRRRRRTCGTRRTRC
2-100R TG_r_n_AAAGG ATT CCRCTCCRR CGRCGRCGCGC TTGRRRTCTGGGGCCRRGGGRCRGT
U M
￿
M
￿
J6
C
￿
U-0-0-J Joining
1
￿
10
OMP1
20
￿
30
GTRTTRCGRTRTTTTORCTGGTTRTTRTRRC
1-112 TCCCRCRCR T CCRTRTCiR CCCCR TRCTRCT*CRC AGGRGG RCTTTGRCTCCTGGGGCCRGGGRRCCCG
1-130 TCCCARR CCRRCC CRCTRTR RR CTRTTRCCATRTTTTCRCTCGTTRTTR GGCGGGT RCTRCTTTGRCTRCTGGGGCCRGGGMCCCT
U
￿
M
￿
M GTRTTRCGRTRTTTTGRCTOGTTRTTATRRC
1
￿
10
DHP1
20
￿
30
5-138
u
￿
n
￿
. . . . . . . . . . .
￿
Jf
RGGRTRTTGTRGTRGTRCCRGCTGCTRTGCC
1 10 20 30
DLR4
I
￿
DMf
10
GRGTRTRGCRGCTCGTCC
￿
M
DR1/f
1
￿
10
TORCTRCRGTRRCTRC
M
2-11 SC Trrrnrp CA TRCTCTRRCTRC C RTRGCRGCRGCTGGTR TCGRTCRTGGG TTTGRCTRCTGGGGCCRGGGRRCCCT
V
￿
M
￿
Go
GTRTRGCRGCRGCTGGTRC
￿
M
￿
Jf
1
￿
1
OMI
￿
20
DKf
GTGGRTRCRGCTRTGGTTRC M
2-1218 JCCCCTC RRCCCTC CCCCRTR(!RCTTRT CRTR TT TCCG[R ACGGG RRCTGGTTCGRCCCCTGGGGCCRGGGRRCCCT
V M
￿
CTRRCTOGGOR M
￿
JS
1 DM052 10
OLR1
1 10 20 30
RGGRTRTTGTRGTRGTRCCRGCTGCTRTGCC
TGCGAGRGR TCTTTGT GRTRTTGTIIGTRGTIiiiGCTGCTRTGC GGd000
V M
D
￿
U-D-(Inverted)D-J Joining
OKf
1 10 20
GTGGRTRCRGCTRTGGTTRC M
￿
M
1-127 TGCGRGRGR TRRTT TRCRGCTRTGGT CCCC CIR r CRD;TRGTTC GRCCCCT RRCTRGTTCGRCCCCTGGGGCCCRGGGRRCCCT
U M
GGCRTROCRGCTOGTRCTRCTRCRRTRTCCT
￿
J5
30 20
￿
10 1
DM(Inverted)
DK1
1 10 20
GTGGRTRTRGTOOCTRCGRTTRM
￿
M
2-109C TCCCRRA ACT CRRCCRTT C RCCCCRRCRMRCC G RTGGR(!GTCTGGGGCCRRGGGRCCRC
V M GGTRTRRTRIICCRCTCCAIUIRRTCGTRRTRC
J6
30 20 10 1
O04(Inverted)
GRGTRTRGCRGCTCG Can CiTTGRCTRCTGGGGCCRGGGRRCCCT
GRGTRTRGCRGCTCGTCC
i
￿
10
DMf
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U-DIR-D-J joining
B
4-133
DIR
-CRRGCCCRGCCCCCRCCCRGGRGI
￿
M
TGCGAGRCR T COCCRCTR CRCCCCCCO CR TCCCTACCRT RCCCCCR ACTRCTRCTRCTRCGGTRTGGRCGTCTGGGGCCRRGGGACCRC
U M
GTGGRTRTRGGCTRCGRTTRC
￿
J6
1
IpTG
OK1
20
U-D-DIR-J joining
1-151
￿
T ,
￿
"RGRGA TCCTCRTTTTGCTRRRR T
￿
" TRTRGCA ,CR " T " "Tp
￿
R ,
￿
R p . .TRRR "
￿
" " " "R TTGRT RRRCT .GTT
￿
,A
￿
rrr, .r, ,
￿
RG ,GAA
￿
T
U M
￿
-CCGCCCRCRRGCCCRGCCC-
￿
JS
DIR
OKi
1 10
￿
20
GTGGRTRTRGTGGCTRCGRTTRC M
2-106A TGrrAGA G ATAGTGrrrrrGAT CGRCTCCCCRC GG TACTTGRrTACTGGGGCCAGGGAACCCT
U M
￿
-R000CRGCCCCCRCCCR-
DIR
U-01R-J joining
DIR1
-CR¢RG~000T~Rf,IG¢RGR~CC
J2-120D TGCGROR GRpCECRRGARRGAGCC RRTGRCTCGGCCGGGRRGR RCTGOTRCTTCGRTCTCTGGGGCCGTGGCRCCCT
U
￿
D
￿
M
￿
J6
DIR2(Inverted)
-CCGRCGGGGCGCCCTGRGCTCT-
3-109A
￿
TG.rGA "A "A
￿
" T
￿
A N " "T . "R "
￿
T "R
￿
"R C "RG " "TR TTT "RTRTCTM " CRAG " "p
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T
U M
￿
M
￿
J3
DIR2
-GGCCCC40A4CTCAGGG;GCCSCGTCGG-
3-126 TGrQAGR AGCGCA CCCChhT "- "WT dTd "hT66 TGTTCTGGRGAGT A TGGTTC "RC
￿
T ""G " R """AACCOT
U M
￿
D
￿
M
￿
JS
DIR(Inverted)
-GGTQQQT¢QGG"TQ000TTGTG
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U
￿
M
￿
A
Figure 7 .
￿
Examples of unusual VDJ joinings . (A) Three CDR3 sequences with V.-J. joinings without aD segment . (B) One sequence with an
invertedDjoining (V-D-J,,) . (C) Five sequences with doubleDjoinings (V,,D-D-J). (D)Two sequences with double Djoinings with the second
D inverted (V.-D "-D-J .) . (E and F) Three clones containing DIR andD segments (V-DIR-D-J and V,;D-DIRJ) . (G) Four clones containing
DIR segments (including inverted orientation) instead ofD segments (V-DIRJ and V "- DIIRJ). The inverted DIR sequence is shown as the
reverse complementarity strand of the germline D sequences . The sequences from the peripheral blood of the six donors are underlined. The best
homology to published germline D sequences is shown.
whichmay explain the widespread sites ofrearrangement found
in this segment .
There is very little documentation of the frequency ofD
gene usage in a polyclonal lymphocyte population from healthy
adults. The total number of human D genes has been esti-
mated to be -30, based on an organization of five repeats,
each containing sixD gene families (6) . The D5 cluster has
recently been described as duplicated within the V gene
locus (19) . SomeD genes may remain undiscovered. It is most
likely that the DN1-like sequences that we have identified,
which have consistent base pair changes fromknown sequences,
DMI
1
￿
10
￿
20
GGGTATRGCRGCRGCTGGTRC
M
￿
M
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are derived from one of these uncharacterized D genes .
Schroeder et al . (23) reported that theDHQ52 gene segment
is most frequently used (8/15) in H chain transcripts from
a 130-d human fetus. In the results presented here, given the
restraints of maximizing homology, the DXP family appeared
to be the most commonly found (29/111) . Similarly, in 13
somatic D sequences published by Ichihara et al . (6), seven
were assigned to the DXP family. Thus, these studies may
indicate that the expression or selection of specificD gene
segments differ according to the developmental stage of the
individual . It is also possible that the number of functionalgermlineDXP family members could be higher than for other
D family members through duplication .
As observed previously, theseresults indicate that, in general,
all three reading frames are used in humanD regions to make
productive rearrangements (6) . However, there may be seg-
ments (DA1, D21/9, DM1) where a single reading frame is
preferentially used, as is usually foundamong murineD regions
(24). Translation of theCDR3 sequences indicates that v75%
of these rearrangements are in the correct reading frame to
allow translation of a functional H chain . Previous analysis
of Abelson murine leukemia virus-transformed murine B cells
indicated that -40% of the cells contained twoV  -DJ .
rearrangements, of which, one was productive and one was
nonproductive (25) . Since peripheral B cells would be ex-
pected to possess at least one productive rearrangement, this
frequency of nonproductiveV  -DJ . rearrangements would
predict that 71% (100/140) of theCDR3 regions would con-
tain an in-frame rearrangement . This predicted frequency is
in close accord with the number observed.
We have shown that tetrameric palindromic nucleotides,
whose formation have been originally described in detail by
Lafaille et al . (21), are most frequently found at the V-N
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and N-DH junctions in the human CDR3, while they are
rare at the D-N andN-J. borders. This finding follows the
observation that nucleotides in the 3' end and of theD seg-
ments and the 5' end of the JH segments appear to be fre-
quently removed by exonuclease activity.
Finally, we have found that unusual rearrangements make
up a small but notable amount (ti10%) of the rearranged
IgH population . DIR segments, as described by Ichihara et
al . (6) as being D-like sequences with irregular spacer lengths
betweenjoining signals, which could be involved in DIR-D
or D-DIRjoining by inversion or deletion, appeared to be
used in our population. Also, we have found examples ofD-D
fusions resulting in both direct and indirect (inverted) V.-D-
D-J. recombination . The mechanism that can account for
these D-D fusions has been elegantly described in the mouse
byMeek et al . (26), and previously proposed as a mechanism
for creating additional antibody diversity by Kurosawa and
Tonegawa (3) . It is not clear if the examples of apparent
V.-J. joining result from deletions ofD in DJH joinings or
reflect extensive exonuclease modification of theD segment
inV .-DJ . joinings.
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